No Data
No Data
WuXi Biologics Schedules Key Financial Review
Wuxi Bio (02269.HK) held a board of directors meeting on August 21 to consider and approve the interim performance.
Wuxi Bio (02269.HK) announced that the board of directors will convene a meeting in Hong Kong on August 21, 2024 (Wednesday) to consider and approve the interim performance of the group for the six months ending June 30, 2024 (including).
WUXI BIO: DATE OF BOARD MEETING
Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$23.25 From HK$53.65, Keeps at Buy
Wuxi Biologics Stock Looks Undervalued -- Market Talk
Wuxi Biologics Target Price Cut to HK$23.25 From HK$53.65 by Nomura >2269.HK
No Data